Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery

Last updated: March 27, 2019
Sponsor: Nationwide Children's Hospital
Overall Status: Trial Not Available

Phase

N/A

Condition

Heart Disease

Pentalogy Of Cantrell

Congenital Heart Disease

Treatment

N/A

Clinical Study ID

NCT02709200
IRB13-00127
  • Ages > 6
  • All Genders

Study Summary

This is a prospective study looking at the effects of dexmedetomidine on pacemaker function in patients who have surgery for congenital heart disease utilizing cardiopulmonary bypass (CBP). For the purpose of the study, no change in intraoperative care will be dictated. The use of dexmedetomidine will be left up to the discretion of the treating physicians. The study will involve only the collection of data regarding the amplitude required to capture and specific demographics and intraoperative features including cross clamp time, time on CPB, and vasoactive agents that were and are being administered. In addition to these data, it will be noted whether dexmedetomdine was used or not and whether it is being administered on arrival to the CTICU.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with temporary surface pacemaker leads following surgery for congenital heartdisease.

Exclusion

Exclusion Criteria:

  • Patients with single ventricle anatomy

  • Patients receiving epinephrine

  • Infants less than 6 months of age

Study Design

Study Start date:
February 01, 2016
Estimated Completion Date:
March 11, 2019

Connect with a study center

  • Nationwide Children's Hospital

    Columbus, Ohio 43205
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.